HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lambert, A. P. Articles by Hattersley, A. T. Search for Related Content PubMed PubMed Citation Articles by Lambert, A. P. Articles by Hattersley, A. T. Social Bookmarking                What's this?

Identifying Hepatic Nuclear Factor 1 Mutations in Children and Young Adults With a Clinical Diagnosis of Type 1 Diabetes

¹ Department of Diabetes and Metabolism, Division of Medicine, University of Bristol, Bristol, U.K.
² Centre for Molecular Genetics, Peninsular Medical School, Exeter, U.K.
³ Chiltern Diabetes Centre, Wycombe Hospital, High Wycombe, Buckinghamshire, U.K.

OBJECTIVE—HNF-1 gene mutations (MODY3) present with marked hyperglycemia in lean young adults and may, therefore, be mistaken for type 1 diabetes, with implications for individual treatment and risk of diabetes in other family members. We examined the prevalence of HNF-1 mutations in families with three generations of diabetes identified in a population-based study of childhood diabetes, representing a subpopulation in which misclassification was likely.

RESEARCH DESIGN AND METHODS—In a study population of 1,470 families, 36 families (2.4%) with three affected generations were identified. In the 18 families in whom DNA samples were available, islet autoantibody testing, HLA class II genotyping, and HNF-1 sequencing were performed.

RESULTS—At least one islet autoantibody was found in 13 of 14 probands, and diabetes-associated HLA class II haplotypes were found in 17 of 18. One proband, who had no islet autoantibodies and was homozygous for the protective HLA haplotype DRB1*02-DQB1*0602, had a novel HNF-1 heterozygous nonsense mutation (R54X). This mutation cosegregated with diabetes in the family. The proband, his brother, mother, and maternal grandmother were diagnosed with type 1 diabetes aged 14–18 years and treated with insulin (0.39–0.74 units/kg) from diagnosis. The mother has since been successfully transferred to sulfonylurea treatment.

CONCLUSIONS—Family history alone is of limited value in identification of individuals with HNF-1 mutations, and we propose a stepwise approach that restricts sequencing of the HNF-1 gene to those with a family history of diabetes who also test negative for islet autoantibodies.

Abbreviations: BOX, Bart’s Oxford • HNF, hepatocyte nuclear factor • MODY, maturity-onset diabetes of the young

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. Narendran, E. Estella, and S. Fourlanos Immunology of type 1 diabetes QJM, August 1, 2005; 98(8): 547 - 556. [Full Text] [PDF]

				E. L. Edghill, A. L. Gloyn, K. M. Gillespie, A. P. Lambert, N. T. Raymond, P. G. Swift, S. Ellard, E. A.M. Gale, and A. T. Hattersley Activating Mutations in the KCNJ11 Gene Encoding the ATP-Sensitive K+ Channel Subunit Kir6.2 Are Rare in Clinically Defined Type 1 Diabetes Diagnosed Before 2 Years Diabetes, November 1, 2004; 53(11): 2998 - 3001. [Abstract] [Full Text] [PDF]

				M. Shepherd, E. R. Pearson, J. Houghton, G. Salt, S. Ellard, and A. T. Hattersley No Deterioration in Glycemic Control in HNF-1{alpha} Maturity-Onset Diabetes of the Young Following Transfer From Long-Term Insulin to Sulphonylureas Diabetes Care, November 1, 2003; 26(11): 3191 - 3192. [Full Text] [PDF]